<DOC>
	<DOCNO>NCT01649401</DOCNO>
	<brief_summary>The main objective study determine whether use PARI LC Sprint Sp nebulizer treatment asthma child 36 month reduces duration hospitalization .</brief_summary>
	<brief_title>Efficacy PARI LC Sprint Sp Nebulizer Acute Asthma Attack Hospitalized Children Less Than 36 Months Age</brief_title>
	<detailed_description>The secondary objective study evaluate whether use LC Sprint Sp Nebulizer result : A-shortened duration oxygen-dependence . B-reduced side effect assess patient 's heart rate 30 minute first aerosol note occurrence desaturation &lt; 90 % nebulisation session . C-increased acceptance aerosol , measure via questionnaire give patient 's parent end hospitalization ( single questionnaire complete either parent parent ) . D-shortened length stay base follow discharge criterion : observation respiratory severity score ≤ 2 ( Clinical Asthma Score ( CAS ) ) least 12 consecutive hour transcutaneous oxygen saturation ( SpO2 ) &gt; 94 % awake &gt; 91 % sleep .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>The parent legal representative must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient attack moderate severe asthma ( least third episode wheeze dyspnea since birth ) require hospitalization define follow criterion : require oxygen : SpO2 &lt; 92 % room air ( CAS ≤ 4/10 ) And / CAS &gt; 4/10 ( 3 attempt nebulized salbutamol session 1 hour emergency care ) . The patient participate another study The patient already include study previous time The patient exclusion period determine previous study The patient judicial protection , tutorship curatorship The parent legal representative refuse sign consent It impossible correctly inform parent legal representative The patient contra indication treatement use study Patient bear &lt; 34 week pregnancy bronchdysplasic First second episode bronchiolitis Asthma attack CAS score ≤ 4/10 inpatient basis nonbreathing related motive . Acute severe Asthma attack : hypercapnia , impaired consciousness , need hospitalization intensive care , need mechanical ventilation , need salbutamol IV Patient know congenital heart disease Patient chronic respiratory disease asthma Patient encephalopathy Patient know immune deficiency CAS ≤ 2 transcutaneous oxygen saturation ( SpO2 ) &gt; 94 % awake &gt; 91 % asleep least 12h</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>nebulizer</keyword>
	<keyword>PARI LC Spring SP</keyword>
</DOC>